 REHOVOT, Israel, Nov. 6, 2019 PRNewswire -- Canonic, a wholly owned subsidiary of Evogene Ltd. EVGN EVGN.TA focused on the development of medical cannabis products, announces today the initiation of its cultivation and breeding program of cannabis varieties with unique genomic profiles for the development of medical cannabis products. The initiation of cannabis cultivation follows: 1 successfully importing widely genetically diverse cannabis lines originating from different territories, 2 establishment of cannabis dedicated RD; facilities, including greenhouses, a molecular lab and tissue culture rooms and 3 receipt of the required regulatory approvals from the Israeli Medical Cannabis Agency IMCA. 